Dave Williams

Williams holds a degree in Accounting and Management from Scranton University and retired in 2008 as Chairman & CEO of Sanofi Pasteur, the vaccines business of Sanofi-Aventis Group. Williams’ thirty years with the company was marked by his rise from Finance Manager to General Manager of the U.S. Business unit, to being named the company’s U.S. President of the company. He was later named Global President & COO in 1998. Williams’ leadership moved the company from a niche vaccine business to the global leader in vaccine development, production, and sales, with 2007 revenues of more than the U.S. $6 billion. Sanofi Pasteur is the largest vaccine business in the world and but also provides the broadest range of vaccines available from a single company.

Under Williams’ guidance, more than one billion doses of Sanofi Pasteur’s lifesaving vaccines were administered to more than 500 million people around the world each year, representing more than 25% of the global vaccine market. The company grew to almost 13,000 employees, licensed more than 30 new vaccines, and launched hundreds of business development programs under Williams’ leadership.